MedPath

Time Restricted Feeding, Muscle, and Metabolism

Not Applicable
Recruiting
Conditions
Overweight
Obesity
Interventions
Other: Control group - time restricted feeding only
Dietary Supplement: Whey protein supplement
Dietary Supplement: Ketogenic aid
Registration Number
NCT04949451
Lead Sponsor
University of Arkansas, Fayetteville
Brief Summary

Effective nutrition strategies for combatting and/or preventing obesity still need to be identified. This has been the case despite the numerous and different approaches that have been taken. Potential targets for combatting/preventing obesity have been identified, but long-term solutions have not emerged. This study uses time restricted feeding to study the role of dietary protein in obesity prevention and/or treatment. The objectives are to determine the role of skeletal muscle mass as a driver of energy-sensing mechanisms and peripheral signals that regulate appetite and energy intake in overweight and obese adults and to determine the effects of protein timing on muscle mass to regulate appetite and energy intake in overweight and obese adults.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Resides in Northwest Arkansas
  • Age 25-50 years
  • BMI > 25
  • All ethnicities
  • Female and male
Exclusion Criteria
  • Food allergies
  • Pregnant or breastfeeding
  • Dietary restrictions (e.g. vegetarian, vegan, etc.)
  • Trying to lose weight in last 3 months
  • Pre-existing health conditions related to obesity (e.g. cardiovascular disease, diabetes, hypertension)
  • Prescription medications related to heart disease or type 2 diabetes
  • Fear of needles
  • Smoker or vaping
  • Currently taking protein supplements or other nutritional supplements which may interfere with study outcomes
  • Consumes >4 alcoholic beverages per week

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TRF-CControl group - time restricted feeding onlyFollows time restricted feeding protocol.
TRF-PWhey protein supplementFollows time restricted feeding protocol, consumes protein supplement
TRF-SKetogenic aidFollows time restricted feeding protocol, consumes ketogenic supplement
Primary Outcome Measures
NameTimeMethod
Body compositionChange is being assessed at baseline and final day (day 120) of the intervention.

Body composition measured using dual x-ray absorptiometry to determine the ration of lean/fat-free mass to fat mass.

Secondary Outcome Measures
NameTimeMethod
GritChange is being assessed at baseline, 4, 8, and 12 weeks

Grit will be assessed using the grit questionnaire.

Amino acids and metabolitesChange is being assessed at baseline, 4, 8, and 12 weeks

Blood will be collected and plasma amino acids and metabolites will be assessed using commercially available kit for amino acid analysis for all circulating amino acids.

Whole body protein turnoverChange is being assessed at baseline and final day (day 120) of the intervention.

Whole body protein turnover will be measured using 15N-alanine

Muscle massChange is being assessed at baseline and final day (day 120) of the intervention.

Muscle mass will be measured using D3-creatine

Body weightChange is being assessed at baseline, 4, 8, and 12 weeks.

Body weight will be measured in kilograms.

SleepChange is being assessed at baseline and 12 weeks

Sleep will be assessed using wrist Actigraphy for sleep duration and total time in bed.

Sleep QualityChange is being assessed at baseline, 4, 8, and 12 weeks

Sleep quality will be measured using the Pittsburgh Sleep Quality Index survey

Self-reported physical activityChange is being assessed at baseline, 4, 8, and 12 weeks

Physical activity will be measured using the iPAQ survey

MoodChange is being assessed at baseline, 4, 8, and 12 weeks

Mood will be assessed using the Profile of Mood States Questionnaire

Hand gripChange is being assessed at baseline, 4, 8, and 12 weeks

Hand grip will be measured using a dynamometer.

Dietary intakeChange is being assessed at baseline, 4, 8, and 12 weeks

Dietary intake will be measured using weighed, 3-day food records

Fasting glucoseChange is being assessed at baseline, 4, 8, and 12 weeks

Glucose will be measured as mg/dl

Trial Locations

Locations (1)

University of Arkansas

🇺🇸

Fayetteville, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath